A CLINICAL EVALUATION OF PANCHAGAVYA GHRITA IN BAL APASMARA (EPILEPSY IN PAEDIATRIC AGE GROUP)
Amit R. Jagtap*, Amruta S. DandekarABSTRACT
Background: Epilepsy is defined as the primary disorder of the brain due to an abnormal and excessive neuronal activity involving cerebral grey matter, resulting in a seizure.
Objective: The objective was to do a clinical evaluation of Panchagavya ghrita in Bal apasmara (epilepsy in paediatric age group).
Materials and Methods: It is a randomized open interventional parallel efficacy drug trial. A total number of 60 patients were selected from the age group of 4 years to 16 years of age. All the patients were recently diagnosed with Idiopathic type of epilepsy and were not on any kind of medication, before the start of the study. The selected patients were randomly divided into two groups – The patients in Group I (n = 30) were given Panchagavya ghrita and patients in Group II (n = 30) were kept on Tab. Tegretol for the study. Both the groups were studied for 12 months to see the efficacy of the drug.
Results: Group I showed Statistically significant results in Frequency of convulsions, Duration of convulsion and Smritinasha (Amnesia). Where as in Group II highly significant results were observed in Frequency of convulsions and duration of convulsion; but not significant results were observed in Smritinasha (Amnesia).
Conclusion: Panchagavya ghrita has shown promising results in the management of Bal - apasmara (Epilepsy in paediatric age group) without any complications and side-effects.
Dr.Amit R. Jagtap, B2/301, Saket Complex, Thane (w), 400601,Maharashtra. Ph: 9869265585/ 9702069848